咳喘灵泡腾片治疗小儿肺炎临床疗效观察

doi:10.3969/j.issn.1674-3865.2016.02.010

Abstract

Abstract: Objective:To evaluate the effects of Kechuanling effervescent tablets in treating children with pneumonia.Methods:A randomized controlled trial was used.Totally 188 cases of children with pneumonia were divided into observation group(93 cases) and the control group(95 cases).The observation group was given Kechuanling Effervescent Tablets combined with basic treatment,and the control group was treated only by basic treatment,then evaluate these two groups of children with the disease concerning overall curative effect,Chinese medicine syndrome efficacy,disappearance time of fever and cough effect and hospital days.Results:The observation group was better than the control group concerning the overall efficiency and effect on Chinese syndromes,the difference being statistical(P<0 05).The effect time and the disappearance time of cough,expectoration and lung roles was shorter in the observation group,and there was statistical difference(P<005).Conclusion:Kechuanling effervescent tablets has the effect of relieving cough,reducing sputum,promoting the absorption of lung roles and shortening the treatment course in the treatment of children with pneumonia.

Key words: Pneumonia, Kechuanling effervescent tablets for children, Randomized controlled trials, Children

ZHANG Xiuying, HU Ling, ZHAO Guohua, JIANG Fengyuan. Clinical study on Kechuanling effervescent tablets in treatment of children with pneumonia[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2016, 8(2): 158-161.

[1]	Hui LIU, Xiaojuan XU, Mingming GENG. Research progress on early diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 391-398.
[2]	Yaowei HAN, Huizhe WANG, Huanmin LI, Liting MA, Dan SUN, Hongxiang CHEN, Shuo YANG, Kunya FU, Mingze LIU, Xinmin LI. Clinical observation of the "Qingxuan Tongluo" method in the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 419-424.
[3]	Yiru JIANG, Fang LIU. Treatment for pediatric bronchopneumonia based on the theory of "subduing what governs the disease" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 456-460.
[4]	Ting CAO, Lei XIONG, Zihao FENG, Dongmei MA. Professor Xiong Lei's clinical experience in treating influenza in children using the method of aromatic herbs for penetrating heat and resolving dampness [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 185-188.
[5]	Xiao TIAN, Huimin CHU. Research progress in integrated traditional Chinese and western medicine treatment of refractory Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 200-206.
[6]	Yue ZHANG, Yanfei YANG, Yanfen WANG, Wenjing GUO. Study on the immunological mechanisms and advances in integrated Chinese-western medicine treatment of severe Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 207-213.
[7]	Muzi LI, Peng ZHOU. Mechanism of oxidative stress in children with viral pneumonia and research advances in integrated Chinese and western medicine interventions [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 214-219.
[8]	Yue YUAN, Zhouying SHI, Zihui DING, Ping LI. Theoretical analysis of traditional Chinese medicine in the prevention and treatment of infectious diseases in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 236-239.
[9]	Qing YANG, Jingnan XUE, Liujin JIA. Experience of Professor Jia Liujin in treating pediatric pneumonia with dyspnea and cough [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 111-115.
[10]	Shihui TANG, Xuefeng WANG, Kexin ZHANG. Professor Wang Xuefeng's exploration in the clinical experience in pediatric pneumonia with dyspnea and cough based on the theory of "What is within manifests without" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 137-140.
[11]	Enhui ZHANG, Linlin WANG, Bo LIU. Analysis of differences in vitamin A, D and E levels in preschool children with allergic diseases and their correlation with risk of severe pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(2): 180-184.
[12]	Sen KONG, Liang ZHANG, Nan LIAO, Guang TU. Application research on risk factor analysis of severe Mycoplasma pneumoniae pneumonia in children based on random forest model [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 71-76.
[13]	Linlin DU, Jun LI, Cancan XU. Correlation of high‐resolution CT features and serum inflammatory levels with induced-sputum pathogen load in children with Mycoplasma pneumoniae pneumonia during acute phase [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 82-87.
[14]	Jinrun LUO, Shiyao ZHANG, Xuefeng WANG, Xiuying ZHANG, Xinran FENG, Yanyan NI, Zhifan TIAN. Expert investigation and research on the common syndrome types and symptoms of CAP in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 503-511.
[15]	Yuang LI, Kejin AN, Chuanqi ZHAO, Shirui SUN, Yuran WANG, Changqing SHEN, Na LI. Etiology and pathogenesis of pediatric pneumonia from the perspective of the "Prolonged-Lying-Impairs-Qi" theory and the collaborative strategy of integrated Chinese-western medicine treatment [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(5): 387-391.

Clinical study on Kechuanling effervescent tablets in treatment of children with pneumonia

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments